There was no significant increased risk of urinary incontinence in
those taking both estrogen and alpha blocker use although confidence intervals were wide
(n=6; AOR 1.97; 95% CI 0.33–11.89; p=0.46). No statistically significant race by
medication use interactions were found (all p>0.05).